ScholarIQanswers from OpenAlex & ORCID
Søren Lund Kristensen
ResearcherPublications, citations & collaboration network
Søren Lund Kristensen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Søren Lund Kristensen have?
ScholarIQindexed works
Søren Lund Kristensen has 220 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Søren Lund Kristensen have?
ScholarIQcitation count
Søren Lund Kristensen has 10,060 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Søren Lund Kristensen?
ScholarIQh-index
Søren Lund Kristensen has an h-index of 47 in OpenAlex.
What is the i10-index of Søren Lund Kristensen?
ScholarIQi10-index
Søren Lund Kristensen has an i10-index of 96 in OpenAlex.
What is the ORCID of Søren Lund Kristensen?
ScholarIQorcid
The ORCID for Søren Lund Kristensen is on the source record.
What is the OpenAlex record for Søren Lund Kristensen?
ScholarIQopenalex
The OpenAlex for Søren Lund Kristensen is on the source record.
What are the most-cited papers on Søren Lund Kristensen?
ScholarIQmost cited works
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Søren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund, Kieran F. Docherty, Naveed Sattar, David Preiss, Lars Køber, Mark C. Petrie, John J.V. McMurray
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, Kelley R. Branch, Stefano Del Prato, Nardev S. Khurmi, Carolyn S.P. Lam, Renato D. Lópes, John J.V. McMurray, Richard E. Pratley, Julio Rosenstock, Hertzel C. Gerstein
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
Morten Lamberts, Jonas Bjerring Olesen, Martin H. Ruwald, Carolina Malta Hansen, Deniz Karasoy, Søren Lund Kristensen, Lars Køber, Christian Torp‐Pedersen, Gunnar Gislason, Morten Lock Hansen
Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
Søren Lund Kristensen, David Preiss, Pardeep S. Jhund, Iain Squire, José Silva‐Cardoso, Béla Merkely, Felipe A. Martínez, Randall C. Starling, Akshay S. Desai, Marty Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile, John J.V. McMurray, Milton Packer
Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
Morten Lamberts, Gunnar Gislason, Jonas Bjerring Olesen, Søren Lund Kristensen, Anne‐Marie Schjerning Olsen, Anders Pretzmann Mikkelsen, Christine Benn Christensen, Gregory Y.H. Lip, Lars Køber, Christian Torp‐Pedersen, Morten Lock Hansen